Orchestra BioMed Holdings (OBIO) Receivables - Net (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Receivables - Net came in at $84000.0 in Q1 2026, down 5.62% year-on-year from $89000.0 in Q1 2025, and down 11.58% on a QoQ basis from $95000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Receivables - Net (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Receivables - Net data on file, last reported at $84000.0 in Q1 2026.
- On a quarterly basis, Receivables - Net fell 5.62% year-over-year to $84000.0 in Q1 2026; TTM through Mar 2026 was $84000.0, a 5.62% decrease from a year earlier, with the FY2025 full-year figure at $95000.0, up 3.26% from the prior year.
- Receivables - Net for Q1 2026 stood at $84000.0, down from $95000.0 in the prior quarter.
- Over the last five years, Receivables - Net for OBIO reached as high as $171000.0 in Q2 2023 and fell as low as $52000.0 in Q3 2025.
- Historically, Receivables - Net has averaged $91785.7 across 5 years, with a median of $87500.0 in 2023.
- Across the five-year window, Receivables - Net jumped 33.72% in 2024 and sank 54.78% in 2025, its largest moves.
- Year by year, Receivables - Net stood at $96000.0 in 2022, then grew by 3.12% to $99000.0 in 2023, then slipped by 7.07% to $92000.0 in 2024, then increased by 3.26% to $95000.0 in 2025, then slipped by 11.58% to $84000.0 in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $84000.0 in Q1 2026, $95000.0 in Q4 2025, and $52000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84,000.00 |
| Mar 31, 2026 | 84,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 89,000.00 |
| Mar 31, 2025 | 89,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Mar 31, 2024 | 67,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |